Purisys has been acquired by the Siegfried Group and continues to provide all existing services as part of the Siegfried Acceleration Hub, including preclinical, early-phase development and manufacturing, reference standards and small-scale GMP manufacturing for commercial APIs.
Your partner for early-phase development and manufacturing
The Siegfried Acceleration Hub, now also including Purisys, is your comprehensive partner for preclinical and early-phase drug development and manufacturing. From phase-appropriate analytical and validation method development to scalable manufacturing processes, we provide the capabilities and support needed to accelerate your path from concept to clinic.
Accelerating early-phase drug development
We provide seamless support from preclinical through early phases to commercial manufacturing, including scale-up, technology transfer, validation, and product launch. Supported by DMFs across the U.S., Canada, Japan, and the EU.
Based in the
United States
Our local presence enables real-time collaboration, reducing delays and enabling efficient scale-up. We ensure regulatory compliance, transparency, and faster development by eliminating offshore transfer risks.
Seamless transfer into Siegfried's network
Smooth transition into Siegfried’s global manufacturing network from early phase through to commercial production, all from a single partner
Decades of
experience
An agile team with extensive experience in accelerating drug development through early phases, backed by Siegfried's 150 years of development expertise.
.jpg?width=2000&name=20230424_Siegfried_Barcelona18803_300ppi_RGB_RZ%20(1).jpg)
